Absci Corporation

NASDAQ:ABSI

2.65 (USD) • At close May 30, 2025
Bedrijfsnaam Absci Corporation
Symbool ABSI
Munteenheid USD
Prijs 2.65
Beurswaarde 338,031,350
Dividendpercentage 0%
52-weken bereik 2.01 - 6.33
Industrie Biotechnology
Sector Healthcare
CEO Mr. Sean McClain
Website https://www.absci.com

An error occurred while fetching data.

Over Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.

Vergelijkbare Aandelen

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.87 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

1.88 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

0.486 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

1.18 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

6.875 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

1.25 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.313 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

2.88 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

7.24 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)